MORGANTOWN, W.Va., Aug. 27, 2024 /PRNewswire/ -- The West Virginia University Health System (WVU Medicine) partnered with InVita Healthcare Technologies...
Computer Vision AI and Precision Genomic Collaboration Aims to Increase Early Detection Rates, Improving Survival Chances for Millions DENVER, Aug....
Bezisterim appears to possess broad homeostatic properties relevant to inflammation and human disorders related to aging Patients treated with bezisterim...
LOS ALTOS, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing...
RENO, Nev. and ROCKVILLE, Md., Aug. 23, 2024 /PRNewswire/ -- Melzi Surgical, a medical device company focused on providing innovative technology...
-Validation Studies Confirmed the Assay Can Detect Mpox Clade I and Clade Ib in addition to Clade II- STONY BROOK,...
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial...
JUPITER, Fla., Aug. 22, 2024 /PRNewswire/ -- Having a sibling with autism spectrum disorder (ASD) can at times leave an...
The Centers for Medicare and Medicaid Services (CMS) assigned a new, unique Health Care Common Procedure Coding System (HCPCS) code...
First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued...
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) announced the signing...
Greenville, South Carolina, Aug. 20, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to...
PLANO, Texas, Aug. 20, 2024 /PRNewswire/ -- StaffDNA®, creator of the Digital Marketplace for Healthcare Careers®, is thrilled to announce its...
From the team behind Dr. Squatch, Jukebox offers handcrafted soaps and deodorants that mix nostalgic yet innovative scents, with natural...
Promising results with Telomir-1 Demonstrates Potential in Promoting Life Quality and Longevity in Senior DogsTAMPA, FL / ACCESSWIRE / August...
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain...
Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential...
Continued progress in Phase 1/2a dose escalation for LAVA-1207, including the monotherapy arm, now enrolling in dose level 12, and...
CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals...